CN110527075A - A kind of preparation method for remembering biological support for the biodegradable body temperature inductive material of 4D printing and the induction of degradable body temperature - Google Patents
A kind of preparation method for remembering biological support for the biodegradable body temperature inductive material of 4D printing and the induction of degradable body temperature Download PDFInfo
- Publication number
- CN110527075A CN110527075A CN201910860265.1A CN201910860265A CN110527075A CN 110527075 A CN110527075 A CN 110527075A CN 201910860265 A CN201910860265 A CN 201910860265A CN 110527075 A CN110527075 A CN 110527075A
- Authority
- CN
- China
- Prior art keywords
- body temperature
- biodegradable
- preparation
- printing
- norbornene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000007639 printing Methods 0.000 title claims abstract description 84
- 230000036760 body temperature Effects 0.000 title claims abstract description 83
- 238000002360 preparation method Methods 0.000 title claims abstract description 43
- 239000000463 material Substances 0.000 title claims description 57
- 230000006698 induction Effects 0.000 title claims description 7
- 230000001939 inductive effect Effects 0.000 title claims 27
- -1 mercapto group small molecule Chemical class 0.000 claims abstract description 68
- 238000006243 chemical reaction Methods 0.000 claims abstract description 44
- 230000009477 glass transition Effects 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 25
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 claims abstract description 17
- 238000002844 melting Methods 0.000 claims abstract description 16
- 230000008018 melting Effects 0.000 claims abstract description 16
- 239000000178 monomer Substances 0.000 claims description 40
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 30
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 27
- 239000003999 initiator Substances 0.000 claims description 26
- 229920001577 copolymer Polymers 0.000 claims description 23
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 17
- 229920005862 polyol Polymers 0.000 claims description 17
- 150000003077 polyols Chemical class 0.000 claims description 17
- 239000003054 catalyst Substances 0.000 claims description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical group ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- 229920002521 macromolecule Polymers 0.000 claims description 14
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 13
- 239000002202 Polyethylene glycol Substances 0.000 claims description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 11
- 229920001610 polycaprolactone Polymers 0.000 claims description 11
- 239000004632 polycaprolactone Substances 0.000 claims description 11
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 10
- 229920000570 polyether Polymers 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 9
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 150000003384 small molecules Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 6
- 150000005846 sugar alcohols Chemical class 0.000 claims description 6
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical group [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 claims description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 238000007334 copolymerization reaction Methods 0.000 claims description 5
- 229920000858 Cyclodextrin Polymers 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 2
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 claims 2
- OTEKOJQFKOIXMU-UHFFFAOYSA-N 1,4-bis(trichloromethyl)benzene Chemical compound ClC(Cl)(Cl)C1=CC=C(C(Cl)(Cl)Cl)C=C1 OTEKOJQFKOIXMU-UHFFFAOYSA-N 0.000 claims 1
- BIMKUWCEBYOHHG-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;3-sulfanylpropanoic acid Chemical class OC(=O)CCS.OCC(CO)(CO)CO BIMKUWCEBYOHHG-UHFFFAOYSA-N 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- SORGMJIXNUWMMR-UHFFFAOYSA-N lanthanum(3+);propan-2-olate Chemical compound [La+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SORGMJIXNUWMMR-UHFFFAOYSA-N 0.000 claims 1
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 239000011540 sensing material Substances 0.000 abstract description 26
- 229920002988 biodegradable polymer Polymers 0.000 abstract description 21
- 239000004621 biodegradable polymer Substances 0.000 abstract description 21
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract description 17
- 125000003518 norbornenyl group Chemical group C12(C=CC(CC1)C2)* 0.000 abstract description 14
- 238000011084 recovery Methods 0.000 abstract description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 7
- 230000005764 inhibitory process Effects 0.000 abstract description 7
- 229910052760 oxygen Inorganic materials 0.000 abstract description 7
- 239000001301 oxygen Substances 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000015556 catabolic process Effects 0.000 abstract description 5
- 238000006731 degradation reaction Methods 0.000 abstract description 5
- 230000010512 thermal transition Effects 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 27
- 230000002792 vascular Effects 0.000 description 24
- 238000005516 engineering process Methods 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 10
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 10
- 238000010146 3D printing Methods 0.000 description 9
- 239000000376 reactant Substances 0.000 description 9
- 238000000016 photochemical curing Methods 0.000 description 8
- 229920000431 shape-memory polymer Polymers 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 6
- 238000000465 moulding Methods 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 229920006237 degradable polymer Polymers 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical group O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000001125 extrusion Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229920000587 hyperbranched polymer Polymers 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- YFPJFKYCVYXDJK-UHFFFAOYSA-N Diphenylphosphine oxide Chemical compound C=1C=CC=CC=1[P+](=O)C1=CC=CC=C1 YFPJFKYCVYXDJK-UHFFFAOYSA-N 0.000 description 3
- JOBBTVPTPXRUBP-UHFFFAOYSA-N [3-(3-sulfanylpropanoyloxy)-2,2-bis(3-sulfanylpropanoyloxymethyl)propyl] 3-sulfanylpropanoate Chemical group SCCC(=O)OCC(COC(=O)CCS)(COC(=O)CCS)COC(=O)CCS JOBBTVPTPXRUBP-UHFFFAOYSA-N 0.000 description 3
- MZRQZJOUYWKDNH-UHFFFAOYSA-N diphenylphosphoryl-(2,3,4-trimethylphenyl)methanone Chemical compound CC1=C(C)C(C)=CC=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MZRQZJOUYWKDNH-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 230000001699 photocatalysis Effects 0.000 description 3
- 229920000747 poly(lactic acid) Polymers 0.000 description 3
- 239000004626 polylactic acid Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- ZKJNETINGMOHJG-GGWOSOGESA-N (e)-1-[(e)-prop-1-enoxy]prop-1-ene Chemical compound C\C=C\O\C=C\C ZKJNETINGMOHJG-GGWOSOGESA-N 0.000 description 2
- IMQFZQVZKBIPCQ-UHFFFAOYSA-N 2,2-bis(3-sulfanylpropanoyloxymethyl)butyl 3-sulfanylpropanoate Chemical compound SCCC(=O)OCC(CC)(COC(=O)CCS)COC(=O)CCS IMQFZQVZKBIPCQ-UHFFFAOYSA-N 0.000 description 2
- YIIPOGLCNUDSBG-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;3-sulfanylpropanoic acid Chemical compound OC(=O)CCS.OC(=O)CCS.OC(=O)CCS.OC(=O)CCS.OCC(CO)(CO)CO YIIPOGLCNUDSBG-UHFFFAOYSA-N 0.000 description 2
- OXBDPDVQOSBFCU-UHFFFAOYSA-N 6-hydroxyhexyl bicyclo[2.2.1]hept-2-ene-5-carboxylate Chemical compound C1C2C(C(=O)OCCCCCCO)CC1C=C2 OXBDPDVQOSBFCU-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 150000005676 cyclic carbonates Chemical class 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002440 hydroxy compounds Chemical class 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical group [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 238000006552 photochemical reaction Methods 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 238000010526 radical polymerization reaction Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- DHBXNPKRAUYBTH-UHFFFAOYSA-N 1,1-ethanedithiol Chemical compound CC(S)S DHBXNPKRAUYBTH-UHFFFAOYSA-N 0.000 description 1
- SRZXCOWFGPICGA-UHFFFAOYSA-N 1,6-Hexanedithiol Chemical compound SCCCCCCS SRZXCOWFGPICGA-UHFFFAOYSA-N 0.000 description 1
- OXBLVCZKDOZZOJ-UHFFFAOYSA-N 2,3-Dihydrothiophene Chemical compound C1CC=CS1 OXBLVCZKDOZZOJ-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 description 1
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SMTOKHQOVJRXLK-UHFFFAOYSA-N butane-1,4-dithiol Chemical compound SCCCCS SMTOKHQOVJRXLK-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000012650 click reaction Methods 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 229940116871 l-lactate Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007155 step growth polymerization reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/148—Materials at least partially resorbable by the body
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
- C08G63/08—Lactones or lactides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/78—Preparation processes
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
- C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
- C08G64/18—Block or graft polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
- C08G64/20—General preparatory processes
- C08G64/30—General preparatory processes using carbonates
- C08G64/305—General preparatory processes using carbonates and alcohols
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G64/00—Macromolecular compounds obtained by reactions forming a carbonic ester link in the main chain of the macromolecule
- C08G64/42—Chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2230/00—Compositions for preparing biodegradable polymers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Materials Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Manufacturing & Machinery (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明公开了一种用于4D打印的生物可降解体温感应材料和可降解体温感应记忆生物支架的制备方法,材料制备方法包括步骤:以末端为羟基的生物可降解高分子为主体,制备末端为巯基或降冰片烯基的多组分生物可降解高分子;生物支架的制备方法包括步骤:多官能团巯基小分子或降冰片烯小分子与生物可降解体温感应材料通过4D打印发生降冰片烯‑巯基光聚合反应得到生物支架;将生物支架加热到熔点温度或玻璃化温度以上并沿着直径方向压缩降低尺寸,然后在零度附近固定临时形状,即得可降解体温感应记忆生物支架。本发明具备打印速度快、无氧阻聚和无收缩性的特点,具有热转变峰宽狭窄、回复速度快、回复温度精确、兼顾可控的降解速率等优势。
The invention discloses a method for preparing a biodegradable body temperature sensing material for 4D printing and a biodegradable body temperature sensing memory biological scaffold. A multi-component biodegradable polymer that is a mercapto group or a norbornene group; the preparation method of the bioscaffold includes the steps of: a multifunctional mercapto group small molecule or a norbornene small molecule and a biodegradable body temperature sensing material generate norbornene by 4D printing ‑Mercapto group photopolymerization reaction to obtain bioscaffolds; the bioscaffolds are heated above the melting point or glass transition temperature and compressed along the diameter direction to reduce the size, and then the temporary shape is fixed near zero to obtain biodegradable body temperature sensing memory bioscaffolds. The invention has the characteristics of fast printing speed, no oxygen inhibition and no shrinkage, and has the advantages of narrow thermal transition peak width, fast recovery speed, accurate recovery temperature, and controllable degradation rate.
Description
技术领域technical field
本发明属于4D打印材料技术领域,具体涉及一种用于4D打印的生物可降解体温感应材料和可降解体温感应记忆生物支架的制备方法。The invention belongs to the technical field of 4D printing materials, and in particular relates to a preparation method of a biodegradable body temperature sensing material for 4D printing and a degradable body temperature sensing memory bio-stent.
背景技术Background technique
心血管疾病已成为世界范围内头号健康杀手。目前针对这一疾病最为有效的治疗手段是冠状动脉腔内球囊成形术(PTCA),即利用支架材料对血管提供径向支撑,防止再狭窄,从而达到治疗的目的。目前最为常用的球囊扩张型支架的植入是将支架压握于端部带有球囊的导丝上,通过球囊导管将支架送至冠脉病变处,然后利用球囊的压力扩张释放支架。据统计显示,在2006年全球每年心血管介入手术约达240万例,并且以每年以40%的速度增长。因此,对于新的支架材料和技术的探索具有很高的科学价值和社会意义。Cardiovascular disease has become the number one health killer worldwide. At present, the most effective treatment for this disease is balloon transluminal coronary angioplasty (PTCA), which uses stent materials to provide radial support for blood vessels to prevent restenosis, thereby achieving the purpose of treatment. The implantation of the most commonly used balloon-expandable stent is to press the stent on the guide wire with a balloon at the end, send the stent to the coronary lesion through the balloon catheter, and then use the pressure of the balloon to expand and release the stent. stand. According to statistics, in 2006, there were about 2.4 million cases of cardiovascular interventional operations in the world each year, and the annual growth rate was 40%. Therefore, the exploration of new scaffold materials and technologies has high scientific value and social significance.
目前血管支架经历了三次革命性的发展,分别是第一代金属裸支架、第二代药物洗脱支架和第三代生物可降解聚合物支架。近年来发现,目前最可靠的方法是使用完全可降解支架,在短时间内起到支撑作用后,在人体内不留下任何金属或聚合物,同时药物释放完毕。由此提出完全可降解支架的概念,在心血管疾病介入治疗中被认为是第三次革命。At present, vascular stents have undergone three revolutionary developments, namely, the first-generation bare metal stents, the second-generation drug-eluting stents, and the third-generation biodegradable polymer stents. In recent years, it has been found that the most reliable method is to use a fully degradable stent, which does not leave any metal or polymer in the human body after playing a supporting role in a short period of time, and the drug is released at the same time. Therefore, the concept of fully degradable stent is proposed, which is considered to be the third revolution in the interventional treatment of cardiovascular diseases.
目前的可降解支架的植入只能利用球囊等辅助物在辅助手术条件下才能被植入人体,操作极其不方便,手术流程繁琐,而且治疗时需要放置器件的外切伤口较大。在可降解支架制造方面,血管支架通常采用传统的注塑、编织、激光加工等方式,装备复杂、工艺复杂、浪费材料、成型后需剔除毛刺和成型微血管支架困难等问题,很难实现个性化定制设计。3D打印成型技术是快速制造任意复杂三维几何形状物体的新型数字化成型技术,具有精度高、速度快和可灵活设计等特点。目前,聚乳酸、聚己内酯等可降解热塑性生物医用材料已经使用熔融沉积成型法3D打印制备各种生物医用材料。The current implantation of degradable stents can only be implanted into the human body under the condition of assisted surgery by using auxiliary materials such as balloons. The operation is extremely inconvenient, the operation process is cumbersome, and the excision wound that needs to place devices during treatment is relatively large. In terms of degradable stent manufacturing, vascular stents usually use traditional injection molding, weaving, laser processing, etc., which are difficult to achieve personalized customization due to problems such as complex equipment, complicated process, waste of materials, need to remove burrs after molding, and difficulty in forming microvascular stents. design. 3D printing molding technology is a new digital molding technology for rapidly manufacturing objects with arbitrary complex three-dimensional geometric shapes. It has the characteristics of high precision, fast speed and flexible design. At present, degradable thermoplastic biomedical materials such as polylactic acid and polycaprolactone have been 3D printed by fused deposition modeling to prepare various biomedical materials.
2013年,在美国加州举办TED(Technology,Entertainment,Design)大会上,来自麻省理工学院的Skylar Tibbits首次公开演示了4D打印技术。4D打印技术的主要原理是在3D打印技术基础上,以智能可变形材料(形状记忆材料使用最为广泛)作为驱动执行单元,利用材料的可变形特性,将成型构件的设计参数、成型工艺、变形行为和最终结构目标等信息设计到初始构型中。成型后利用外场激励介质刺激,通过弯曲、扭曲、膨胀等自我变形获得预设三维空间构型,是一种集成产品设计、制造、装配为一体的创新技术,即4D打印方法。In 2013, at the TED (Technology, Entertainment, Design) conference held in California, USA, Skylar Tibbits from the Massachusetts Institute of Technology publicly demonstrated 4D printing technology for the first time. The main principle of 4D printing technology is based on 3D printing technology, using intelligent deformable materials (shape memory materials are the most widely used) as the drive execution unit, using the deformable characteristics of materials, the design parameters, molding process, deformation Information such as behavior and final structural goals are designed into the initial configuration. After forming, use external field excitation medium to stimulate, and obtain preset three-dimensional space configuration through self-deformation such as bending, twisting, and expansion. It is an innovative technology that integrates product design, manufacturing, and assembly, that is, 4D printing method.
针对可降解聚合物支架目前存在的技术瓶颈问题,最新的4D打印技术可以制备出智能化的具有形状记忆功能的完全可吸收聚合物血管支架。采用4D打印技术加工成型的血管支架,在身体温度的激励下可以发生膨胀等自我变形,最终达到预设的三维空间构型,使其在植入人体时无需球囊扩张即可通过自我变形实现支架与血管内壁的紧密稳定贴合,这种自适应性,能够降低球囊扩张过程对血管壁的强烈冲击、降低血管壁撕裂风险,大大减小外切伤口的大小,减轻病患痛苦。同时,成型过程不受结构复杂性的限制,与传统制造方法相比,更容易满足力学性能和和医学性能的要求。Aiming at the current technical bottleneck of degradable polymer stents, the latest 4D printing technology can prepare intelligent fully absorbable polymer vascular stents with shape memory function. The vascular stent processed and formed by 4D printing technology can undergo self-deformation such as expansion under the excitation of body temperature, and finally achieve a preset three-dimensional space configuration, so that it can be realized through self-deformation without balloon expansion when implanted in the human body. The tight and stable fit between the stent and the inner wall of the blood vessel, this adaptability can reduce the strong impact on the blood vessel wall during the balloon expansion process, reduce the risk of tearing the blood vessel wall, greatly reduce the size of the excision wound, and relieve the pain of the patient. At the same time, the molding process is not limited by the complexity of the structure, and it is easier to meet the requirements of mechanical properties and medical properties compared with traditional manufacturing methods.
利用4D打印技术打印形状记忆血管支架材料已经有相关文献报道和专利技术。专利201410344228.2(一种4D打印成型人工血管支架的方法)利用3D打印制备了形状记忆聚合物血管支架,采用的是熔融沉积3D打印,血管支架没有可降解性能。专利201410832997.7(一种完全可吸收高分子血管支架及其制备方法)利用熔融挤出3D制备了可降解形状记忆支架,该支架材料不具备体温感应形状记忆功能。专利201610232704.0(一种基于3D打印技术制备生物可降解聚合物自扩张式血管支架的方法)利用熔融挤出式3D打印制备了聚乳酸/氧化铁纳米复合材料,形状记忆响应温度接近人体温度。专利201710064389.X(基于形状记忆聚氨酯可降解自扩张4D血管支架及其制备方法)利用熔融挤出3D打印制备了感应温度接近人体温度的可降解形状记忆聚氨酯。专利201710215735.X(一种可视化形状记忆高分子血管支架的制备方法)利用光固化3D打印双键末端改性的六臂可降解高分子制备了血管支架,由于大分子末端是丙烯酸酯双键的光催化自聚反应,光聚合速度慢、有氧阻聚和收缩的缺点。文献(ACS Appl.Mater.Interfaces,2017,9,876-883)报道了一种挤出后光固化的方式制备了聚乳酸/氧化铁血管支架,由于制备工艺是先挤出在光照交联,制备过程缓慢,工艺步骤复杂,而且形状记忆响应温度远高于人体温度。Using 4D printing technology to print shape memory vascular stent materials has related literature reports and patented technologies. Patent 201410344228.2 (a method for forming artificial vascular stents by 4D printing) uses 3D printing to prepare shape memory polymer vascular stents. Fused deposition 3D printing is used, and vascular stents have no degradable properties. Patent 201410832997.7 (a fully absorbable polymer vascular stent and its preparation method) uses melt extrusion 3D to prepare a degradable shape memory stent. The stent material does not have the function of body temperature induction shape memory. Patent 201610232704.0 (a method for preparing a biodegradable polymer self-expanding vascular stent based on 3D printing technology) uses melt extrusion 3D printing to prepare polylactic acid/iron oxide nanocomposites, and the shape memory response temperature is close to human body temperature. Patent 201710064389.X (degradable self-expanding 4D vascular stent based on shape memory polyurethane and its preparation method) uses melt extrusion 3D printing to prepare degradable shape memory polyurethane with a sensing temperature close to human body temperature. Patent 201710215735.X (a method for preparing a visualized shape memory polymer vascular stent) prepared a vascular stent by using a six-arm degradable polymer modified by photocuring 3D printing at the end of a double bond. Since the end of the macromolecule is an acrylate double bond Photocatalytic self-polymerization reaction, slow photopolymerization speed, oxygen inhibition and shrinkage. The literature (ACS Appl. Mater. Interfaces, 2017, 9, 876-883) reported that a polylactic acid/iron oxide vascular stent was prepared by extruding and photocuring. Since the preparation process is first extruded and cross-linked by light, the preparation process Slow, complex process steps, and shape memory response temperature is much higher than human body temperature.
目前可实现4D打印的可降解形状记忆血管支架大部分是通过熔融挤出3D打印技术制备,支架是由层层堆砌打印而成,而且相互没有交联,力学性能相对薄弱。对于目前的直接光固化4D打印的血管支架是通过丙烯酸酯末端功能化的大分子通过光交联制备,由于丙烯酸酯键的光聚合,存在遇氧阻聚,光固化不完全,而且延长了固化时间。另外,丙烯酸酯键是一个自聚合体系,容易发生凝胶过早发生,产生应力集中,会引起样品起皱和翘曲。步增长巯基—烯光反应不仅具有协同光聚合反应和步增长自由基聚合反应的优势,还具备无氧阻聚、无应力集中、引发剂用量少和聚合反应速度快的特点。At present, most of the degradable shape memory vascular stents that can realize 4D printing are prepared by melt extrusion 3D printing technology. The stents are printed by stacking layers, and there is no cross-linking with each other, and the mechanical properties are relatively weak. For the current direct photocuring 4D printed vascular stents, the macromolecules functionalized by acrylate end are prepared by photocrosslinking. Due to the photopolymerization of acrylate bonds, there is oxygen inhibition, photocuring is not complete, and the curing is prolonged. time. In addition, the acrylate bond is a self-polymerizing system, prone to premature gelation, resulting in stress concentrations that can cause wrinkling and warping of the sample. The step-growth thiol-ene photoreaction not only has the advantages of synergistic photopolymerization and step-growth free radical polymerization, but also has the characteristics of no oxygen inhibition, no stress concentration, less amount of initiator and fast polymerization rate.
光引发的巯基和可均聚型双键单体的光化学反应体系中是一个链增长机理和逐步增长机理相互竞争的光聚合反应,而巯基和非均聚型双键单体光化学反应体系中是单纯的逐步聚合机理。根据点击反应的双键单体反应活性顺序(J.Am.Chem.Soc.2012,134,13804-13817),如图11所示,目前只有降冰片烯(Norbornene)、乙烯基醚(Vinyl ether)和丙烯基醚(Propenyl ether)等少数的单体采取单纯的逐步聚合机理,并且降冰片烯基团的巯基烯光聚合物反应速度最快。The photochemical reaction system of photoinitiated thiol and homopolymerizable double bond monomer is a photopolymerization reaction in which the chain growth mechanism and stepwise growth mechanism compete with each other, while the photochemical reaction system of thiol and non-homopolymerizable double bond monomer is Simple stepwise polymerization mechanism. According to the order of reactivity of double-bond monomers in the click reaction (J.Am.Chem.Soc.2012,134,13804-13817), as shown in Figure 11, currently only norbornene (Norbornene), vinyl ether (Vinyl ether ) and propenyl ether (Propenyl ether) and a small number of monomers adopt a simple step-by-step polymerization mechanism, and the reaction speed of the mercaptoene photopolymer of the norbornene group is the fastest.
鉴于此,目前还缺少一种成型速度快、无氧阻聚和无收缩的4D打印可降解体温感应材料及采用该材料制成的形状记忆血管支架。In view of this, there is still a lack of a 4D printing degradable body temperature sensing material with fast forming speed, no oxygen inhibition and no shrinkage, and a shape memory vascular stent made of this material.
发明内容Contents of the invention
为了解决现有技术存在的上述问题,本发明目的在于提供一种用于4D打印的生物可降解体温感应材料和可降解体温感应记忆生物支架的制备方法。In order to solve the above-mentioned problems existing in the prior art, the object of the present invention is to provide a biodegradable body temperature sensing material for 4D printing and a method for preparing a biodegradable body temperature sensing memory biological scaffold.
本发明所采用的技术方案为:The technical scheme adopted in the present invention is:
一种用于4D打印的生物可降解体温感应材料的制备方法,包括步骤:以在生理温度下末端为羟基的生物可降解高分子为主体,通过对主体末端封端化处理,制备得到在生理温度下可降解的、末端为巯基或降冰片烯基的多组分生物可降解高分子,其作为4D打印的生物可降解体温感应材料使用。A method for preparing a biodegradable body temperature sensing material for 4D printing, comprising the steps of: using a biodegradable polymer whose terminal is a hydroxyl group at a physiological temperature as the main body, and preparing a biodegradable polymer with a physiological temperature by capping the end of the main body. A multi-component biodegradable polymer that is degradable at temperature and terminated with mercapto or norbornene groups is used as a biodegradable body temperature sensing material for 4D printing.
进一步的,所述主体的玻璃化温度或熔点温度为20℃-40℃。Further, the glass transition temperature or melting point of the main body is 20°C-40°C.
进一步的,所述主体的制备方法包括:以D,L-丙交酯或己内酯为主单体;L-丙交酯、己内酯、乙交酯、环酸酐、环碳酸酯、环磷脂或对二氧环己酮中的一种或多种作为共聚单体;经催化剂、引发剂作用后共聚得到多组分共聚物。Further, the preparation method of the main body includes: using D,L-lactide or caprolactone as the main monomer; L-lactide, caprolactone, glycolide, cyclic anhydride, cyclic carbonate, cyclic One or more of phospholipids or p-dioxanone is used as a comonomer; after being acted on by a catalyst and an initiator, a multi-component copolymer is obtained by copolymerization.
进一步的,所述引发剂为二元羟基化合物、多元羟基化合物或低聚物。Further, the initiator is a dihydric hydroxy compound, a polyhydric hydroxy compound or an oligomer.
进一步的,所述引发剂为乙二醇、季戊四醇、小分子多羟基醇、低聚二臂聚乙二醇、多臂聚乙二醇、低聚二臂聚己内酯多元醇、多臂聚己内酯多元醇、低聚二臂聚醚多元醇、三臂聚醚多元醇、环糊精或糖醇。Further, the initiator is ethylene glycol, pentaerythritol, small molecule polyhydric alcohol, oligomeric two-arm polyethylene glycol, multi-arm polyethylene glycol, oligomeric two-arm polycaprolactone polyol, multi-arm poly Caprolactone polyol, oligomeric two-arm polyether polyol, three-arm polyether polyol, cyclodextrin or sugar alcohol.
进一步的,所述催化剂为辛酸亚锡。Further, the catalyst is stannous octoate.
进一步的,制备玻璃化温度为20℃-40℃的主体时,采用的主单体和共聚单体的质量分数按照公式(1)确定:Further, when preparing a body with a glass transition temperature of 20°C-40°C, the mass fractions of the main monomer and comonomer used are determined according to the formula (1):
Tg为主体的玻璃化温度;Tg1、Tg2…Tgn分别为每个参加反应的单体的链段玻璃化温度;n为大于或等于2的正整数;W1、W2…Wn分别为每个参加反应的单体占所有单体的质量分数。T g is the glass transition temperature of the main body; T g1 , T g2 ... T gn are the segment glass transition temperatures of each monomer participating in the reaction; n is a positive integer greater than or equal to 2; W 1 , W 2 ... W n is the mass fraction of each monomer participating in the reaction in all monomers.
进一步的,制备玻璃化温度为20℃-40℃的主体时,引发剂的摩尔量占所有单体总摩尔量的0.02mol%。Further, when preparing a body with a glass transition temperature of 20° C.-40° C., the molar amount of the initiator accounts for 0.02 mol% of the total molar weight of all monomers.
进一步的,所述玻璃化温度为20℃-40℃的主体的分子量为400-2000。Further, the molecular weight of the host whose glass transition temperature is 20°C-40°C is 400-2000.
进一步的,制备熔点为20℃-40℃的主体时,引发剂和各个单体的摩尔比根据所述熔点为20℃-40℃的主体的分子量确定。Further, when preparing a host with a melting point of 20°C-40°C, the molar ratio of the initiator to each monomer is determined according to the molecular weight of the host with a melting point of 20°C-40°C.
进一步的,制备熔点为30℃-40℃的主体时,引发剂用量为所有单体的总重的0.1wt%;主体的分子量为1000-4000。Further, when preparing the main body with a melting point of 30°C-40°C, the amount of the initiator is 0.1 wt% of the total weight of all monomers; the molecular weight of the main body is 1000-4000.
进一步的,所述主体末端封端化处理为降冰片烯基封端处理,所述降冰片烯基封端处理包括步骤:将主体、降冰片烯酰氯和三乙胺用溶剂混匀反应制备得到末端为降冰片烯基的多组分生物可降解高分子。Further, the end-capping treatment of the main body is a norbornene-based end-capping treatment, and the norbornene-based end-capping treatment includes the steps of: mixing and reacting the main body, norbornene acyl chloride and triethylamine with a solvent to obtain A multi-component biodegradable polymer terminated by a norbornene group.
进一步的,所述溶剂为二氯甲烷;所述降冰片烯酰氯、三乙胺和主体羟基的摩尔比为1.2:1.2:1;反应时间为48h;反应温度为室温。Further, the solvent is dichloromethane; the molar ratio of norbornene acid chloride, triethylamine and main hydroxyl group is 1.2:1.2:1; the reaction time is 48h; the reaction temperature is room temperature.
进一步的,所述主体末端封端化处理为巯基封端处理,所述巯基封端处理包括步骤:将主体、巯基乙酸、催化剂和溶剂在氮气氛下回流反应得到末端为巯基的多组分生物可降解高分子。Further, the end-capping treatment of the main body is a mercapto-capping treatment, and the mercapto-capping treatment includes the steps of: reflux reaction of the main body, thioglycolic acid, catalyst and solvent under a nitrogen atmosphere to obtain a multi-component biological compound with a mercapto group at the end. Degradable polymers.
进一步的,所述主体末端封端化处理中,所述主体的羟基与巯基乙酸的摩尔比为1:10。Further, in the end-capping treatment of the main body, the molar ratio of the hydroxyl group of the main body to thioglycolic acid is 1:10.
进一步的,所述主体末端封端化处理中催化剂为一水对甲苯磺酸;一水对甲苯磺酸占单体质量的质量分数为1wt%;所述反应的温度为120℃-126℃,反应时间为24h。Further, the catalyst in the end-capping treatment of the main body is p-toluenesulfonic acid monohydrate; the mass fraction of p-toluenesulfonic acid monohydrate to the monomer mass is 1 wt%; the reaction temperature is 120°C-126°C, The reaction time is 24h.
一种生物可降解体温感应材料4D打印可降解体温感应记忆生物支架的制备方法,包括步骤:将所述生物可降解体温感应材料、溶剂、光引发剂与多官能团巯基小分子或降冰片烯小分子混匀调节至适合打印粘度后,所述多官能团巯基小分子或降冰片烯小分子与生物可降解体温感应材料通过4D打印发生降冰片烯-巯基光聚合反应后得到生物支架;将生物支架加热到熔点温度或玻璃化温度以上并沿着直径方向压缩降低尺寸,然后在零度附近固定临时形状,即得到可降解体温感应记忆生物支架。A method for preparing a biodegradable body temperature sensing material 4D printing degradable body temperature sensing memory biological scaffold, comprising the steps of: combining the biodegradable body temperature sensing material, a solvent, a photoinitiator with a multifunctional mercapto small molecule or a norbornene small molecule After the molecular mixing is adjusted to a suitable printing viscosity, the bioscaffold is obtained after the multifunctional mercapto small molecule or norbornene small molecule and the biodegradable body temperature sensing material undergo a norbornene-mercapto photopolymerization reaction through 4D printing; the bioscaffold Heating above the melting point or glass transition temperature and compressing along the diameter direction reduces the size, and then fixes the temporary shape near zero degrees to obtain a degradable bioscaffold with body temperature sensing memory.
进一步的,所述生物支架为血管支架,所述4D打印的打印条件为紫外光强度30mW/cm-2;打印速度:50mm/h,打印支架尺寸:长度40mm,外径4mm,内径2mm。Further, the biological stent is a vascular stent, and the printing conditions of the 4D printing are ultraviolet light intensity 30mW/cm -2 ; printing speed: 50mm/h, printed stent size: length 40mm, outer diameter 4mm, inner diameter 2mm.
进一步的,所述生物可降解体温感应材料为末端为降冰片烯基的多组分生物可降解高分子;所述生物支架的制备包括如下步骤:将所述生物可降解体温感应材料、溶剂、光引发剂与多官能团巯基小分子混匀调节至适合打印粘度后,通过4D打印得到生物支架;所述多官能团巯基小分子为四(3-巯基丙酸)季戊四醇酯。Further, the biodegradable body temperature sensing material is a multi-component biodegradable polymer with a norbornene group at the end; the preparation of the bioscaffold includes the following steps: mixing the biodegradable body temperature sensing material, solvent, After the photoinitiator is mixed with the multifunctional mercapto small molecule to adjust the viscosity suitable for printing, the bioscaffold is obtained by 4D printing; the multifunctional mercapto small molecule is pentaerythritol tetrakis(3-mercaptopropionate).
进一步的,所述生物可降解体温感应材料为末端为巯基的多组分生物可降解高分子;所述生物支架的制备包括如下步骤:将所述生物可降解体温感应材料、溶剂、光引发剂与降冰片烯小分子混匀调节至适合打印粘度后,通过4D打印得到生物支架;所述降冰片烯小分子为5-降冰片烯-2-羧酸三羟甲基丙烷三酯。Further, the biodegradable body temperature sensing material is a multi-component biodegradable polymer whose terminal is a sulfhydryl group; the preparation of the bioscaffold includes the following steps: mixing the biodegradable body temperature sensing material, a solvent, a photoinitiator After mixing with the norbornene small molecule to adjust the viscosity suitable for printing, the bioscaffold is obtained by 4D printing; the norbornene small molecule is 5-norbornene-2-carboxylic acid trimethylolpropane triester.
进一步的,所述光引发剂为2,4,6(三甲基苯甲酰基)二苯基氧化膦;所述溶剂为三氯甲烷;光引发剂占各物质总重的质量分数为0.5wt%。Further, the photoinitiator is 2,4,6 (trimethylbenzoyl) diphenylphosphine oxide; the solvent is chloroform; the mass fraction of the photoinitiator accounting for the total weight of each substance is 0.5wt %.
本发明的有益效果为:本发明的一种用于4D打印的生物可降解体温感应材料和可降解体温感应记忆生物支架的制备方法,通过末端为羟基的生物可降解高分子为主体,通过对主体末端封端化处理,制备得到末端为巯基或降冰片烯基的多组分生物可降解高分子用于4D打印,克服了传统的4D打印使用丙烯酸酯单体光聚合时会产生收缩的缺点;本发明生物支架通过末端为巯基或降冰片烯基的多组分生物可降解高分子和巯基或降冰片烯小分子通过降冰片烯-巯基光固化打印制备可降解体温感应的记忆生物支架;这种降冰片烯-巯基光固化打印具有成型速度快、无氧阻聚和无收缩的优点。同时,与丙烯酸酯基自由基聚合相比,降冰片烯-巯基步增长聚合形成的聚合物网络具有规整性,热转变峰宽狭窄,形状回复更快,回复温度更精确的优点,另外,其还能够兼顾可控的降解速率;本发明的生物支架在身体温度的激励下可以发生膨胀等自我变形,最终达到预设的三维空间构型,使其在植入人体时无需球囊扩张即可通过自我变形实现支架与血管内壁的紧密稳定贴合。由于生物支架具有生物可降解性,无需二次手术取出,可大大减减轻病患痛苦。The beneficial effects of the present invention are: a preparation method of a biodegradable body temperature sensing material for 4D printing and a biodegradable body temperature sensing memory bioscaffold of the present invention, the main body is a biodegradable polymer with a hydroxyl group at the end, and the The end-capping treatment of the main body prepares multi-component biodegradable polymers with mercapto or norbornene groups at the end for 4D printing, which overcomes the disadvantage of shrinkage when acrylate monomers are photopolymerized in traditional 4D printing ; The bioscaffold of the present invention prepares a biodegradable body temperature-sensing memory bioscaffold through photocuring and printing of a multi-component biodegradable polymer with a thiol or norbornene group at the end and a thiol or norbornene small molecule; This norbornene-mercapto photocurable printing has the advantages of fast molding speed, no oxygen inhibition and no shrinkage. At the same time, compared with acrylate-based radical polymerization, the polymer network formed by norbornene-mercapto step-growth polymerization has regularity, narrow thermal transition peak width, faster shape recovery, and more accurate recovery temperature. In addition, its It can also take into account the controllable degradation rate; the biological scaffold of the present invention can undergo self-deformation such as expansion under the excitation of body temperature, and finally achieve a preset three-dimensional space configuration, so that it can be implanted into the human body without balloon expansion. The tight and stable fit between the stent and the inner wall of the blood vessel is realized through self-deformation. Because the biostent is biodegradable, it does not need to be taken out by secondary surgery, which can greatly reduce the suffering of patients.
附图说明Description of drawings
图1基于降冰片烯-巯基光聚合4D打印技术的打印原理图。Figure 1 The printing principle diagram based on norbornene-mercapto photopolymerization 4D printing technology.
图2降冰片烯封端四臂聚D,L-丙交酯的核磁氢谱图。Figure 2 The H NMR spectrum of norbornene-terminated four-arm poly D,L-lactide.
图3巯基封端四臂聚D,L-丙交酯的核磁氢谱。Fig. 3 H NMR spectrum of mercapto-terminated four-arm poly D, L-lactide.
图4降冰片烯封端四臂聚D,L-丙交酯和四(3-巯基丙酸)季戊四醇酯在10mW/m2的紫外光下1~2s形成凝胶的示意图。Fig. 4 Schematic diagram of gel formation of norbornene-terminated four-arm poly D, L-lactide and tetrakis(3-mercaptopropionate) pentaerythritol ester under 10mW/m2 ultraviolet light for 1-2s.
图5降冰片烯封端四臂聚D,L-丙交酯和四(3-巯基丙酸)季戊四醇酯交联形状记忆聚合物玻璃化转变区图(狭窄的半峰宽)。Fig. 5 Glass transition region diagram (narrow half-peak width) of norbornene-terminated four-arm poly D, L-lactide and tetrakis(3-mercaptopropionate) pentaerythritol ester cross-linked shape memory polymer.
图6降冰片烯封端四臂聚D,L-丙交酯和四(3-巯基丙酸)季戊四醇酯交联形状记忆聚合物在不同应变下的形状记忆性能图。Fig. 6 The shape memory properties of norbornene-terminated four-arm poly D, L-lactide and tetrakis (3-mercaptopropionate) pentaerythritol ester cross-linked shape memory polymer under different strains.
图7降冰片烯封端四臂聚D,L-丙交酯和四(3-巯基丙酸)季戊四醇酯交联形状记忆聚合物的形状记忆循环性能图。Fig. 7 The shape memory cycle performance diagram of norbornene-terminated four-arm poly D, L-lactide and tetrakis (3-mercaptopropionate) pentaerythritol ester cross-linked shape memory polymer.
图8降冰片烯封端四臂聚D,L-丙交酯和四(3-巯基丙酸)季戊四醇酯交联形状记忆聚合物的形状记忆回复展示图(在玻璃化温度的热水中1s即可回复)。Figure 8 The shape memory recovery of norbornene-terminated four-arm poly D, L-lactide and tetrakis (3-mercaptopropionate) pentaerythritol ester cross-linked shape memory recovery diagram (in hot water at glass transition temperature for 1 s to reply).
图9羟基封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物的Tanδ–温度曲线。Fig. 9 Tanδ–temperature curve of hydroxyl-terminated four-arm poly D,L-lactide-co-trimethylene carbonate copolymer.
图10羟基封端的聚(己内酯-co-三亚甲基碳酸酯)熔点曲线。Figure 10 Melting point curve of hydroxyl terminated poly(caprolactone-co-trimethylene carbonate).
图11是巯基烯反应中双键单体反应活性顺序图。Figure 11 is a diagram of the reactivity sequence of double-bond monomers in the mercaptoene reaction.
具体实施方式Detailed ways
下面结合附图及具体实施例对本发明做进一步阐释。The present invention will be further explained below in conjunction with the accompanying drawings and specific embodiments.
本发明的一种用于4D打印的生物可降解体温感应材料和可降解体温感应记忆生物支架的制备方法,包括生物可降解体温感应材料的制备方法和可降解体温感应记忆生物支架的制备方法两个大的技术方案。分别具体说明如下:A preparation method of a biodegradable body temperature sensing material and a biodegradable body temperature sensing memory bio-stent for 4D printing according to the present invention, including a preparation method of a biodegradable body temperature sensing material and a preparation method of a biodegradable body temperature sensing memory bio-stent a large technical solution. The specific descriptions are as follows:
生物可降解体温感应材料的制备方法,通过采用末端为羟基的生物可降解高分子(即羟基封端的生物可降解高分子)为基本的主体原料,制备可以在生理温度下降解的、末端为巯基或降冰片烯基的多组分生物可降解高分子,即巯基或降冰片烯基封端的多组分生物可降解高分子。该材料运用到4D打印领域,是通过巯基或降冰片烯基封端的多组分生物可降解高分子与相应的二臂或多臂降冰片烯或巯基封端的可降解大分子,在光催化作用下,发生光催化降冰片烯-巯基点击化学反应实现的。通过该反应制得的生物支架,如血管支架,具备形状构造回复速度快、回复温度更加精确和降解速率可控的优点。A method for preparing a biodegradable body temperature sensing material, by using a biodegradable polymer terminal with a hydroxyl group (ie, a hydroxyl-terminated biodegradable polymer) as the basic main raw material to prepare a material that can be degraded at a physiological temperature and has a sulfhydryl group terminal. or norbornene-based multicomponent biodegradable polymers, that is, multicomponent biodegradable polymers terminated by mercapto or norbornene groups. The material is applied to the field of 4D printing. It is a multi-component biodegradable polymer terminated by a mercapto or norbornene group and a corresponding two-arm or multi-arm norbornene or mercapto-terminated degradable macromolecule. Next, photocatalytic norbornene-sulfhydryl click chemistry reaction occurred. The biostents prepared by this reaction, such as vascular stents, have the advantages of fast recovery of shape and structure, more accurate recovery temperature and controllable degradation rate.
为了使本发明的生物可降解体温感应材料能在生理温度下(即生物体内的维持生理活动的温度)发生降解,本发明首先对作为主体材料的末端为羟基的生物可降解高分子进行了可降解改进。In order to make the biodegradable body temperature sensing material of the present invention degrade at physiological temperature (that is, the temperature for maintaining physiological activities in the living body), the present invention first degrades the biodegradable polymer whose terminal is a hydroxyl group as the main material. Degradation improvements.
具体通过如下两种方式来保证。一是通过控制主体材料的玻璃化温度在20℃-40℃;二是通过控制主体材料的熔点在20℃-40℃来实现。Specifically, it is guaranteed in the following two ways. One is by controlling the glass transition temperature of the main material at 20°C-40°C; the other is by controlling the melting point of the main material at 20°C-40°C.
本发明的玻璃化温度在20℃-40℃的主体是以D,L-丙交酯或己内酯为主单体;L-丙交酯、己内酯、乙交酯、环酸酐、环碳酸酯、环磷脂或对二氧环己酮中的一种或多种作为共聚单体;经催化剂、引发剂作用后共聚得到多组分共聚物,并通过公式(1)控制产物的组成以及分子量来得到。具体地,举例如下:The glass transition temperature of the present invention is mainly based on D, L-lactide or caprolactone at 20°C-40°C; L-lactide, caprolactone, glycolide, cyclic anhydride, cyclic One or more of carbonate, cyclophospholipid or p-dioxanone are used as comonomers; multi-component copolymers are obtained by copolymerization after the action of catalyst and initiator, and the composition of the product is controlled by formula (1) and Molecular weight is obtained. Specifically, examples are as follows:
以辛酸亚锡为催化剂,二元或多元羟基化合物或低聚物为引发剂,以D,L-丙交酯为主单体,L-丙交酯、己内酯、乙交酯、环酸酐、环碳酸酯、环磷脂、对二氧环己酮等中的一种、两种或三种以上为共聚单体。将上述所需反应物、引发剂和催化剂加入无水无氧反应瓶,抽真空,通氮气,反复三次。反应体系密封后在130℃的油浴下反应24h。反应完毕后,反应体系降至室温,加入适量的三氯甲烷溶解产物。将反应混合物缓慢滴加到冷甲醇中沉淀,其中甲醇的体积是5-10倍反应物的三氯甲烷溶液体积,过滤后再次溶解和沉淀,连续沉淀三次,得到的最终产物。其中,引发剂的摩尔用量占所有单体总摩尔量的摩尔百分数为0.02mol%;引发剂和单体的摩尔比根据所需分子量计算,最终合成的大分子分子量在400~2000左右;主单体和共聚单体的配比根据FOX方程计算,使其玻璃化温度在20~40℃左右,例如,三种单体共聚的计算如下:Use stannous octoate as catalyst, binary or polyhydric hydroxyl compound or oligomer as initiator, D, L-lactide as the main monomer, L-lactide, caprolactone, glycolide, cyclic anhydride , cyclocarbonate, cyclophospholipid, p-dioxanone, etc., one, two, or more than three are comonomers. Add the above-mentioned required reactants, initiators and catalysts into an anhydrous and oxygen-free reaction flask, vacuumize, and pass nitrogen, and repeat three times. After the reaction system was sealed, it was reacted in an oil bath at 130°C for 24 hours. After the reaction was completed, the reaction system was cooled to room temperature, and an appropriate amount of chloroform was added to dissolve the product. The reaction mixture is slowly dropped into cold methanol for precipitation, wherein the volume of methanol is 5-10 times the volume of the chloroform solution of the reactant. After filtering, it dissolves and precipitates again, and precipitates continuously for three times to obtain the final product. Wherein, the molar dosage of the initiator accounts for 0.02mol% of the total molar weight of all monomers; the molar ratio of the initiator and the monomer is calculated according to the required molecular weight, and the molecular weight of the final synthesized macromolecule is about 400 to 2000; the main monomer The ratio of monomers and comonomers is calculated according to the FOX equation so that the glass transition temperature is around 20-40°C. For example, the calculation of the copolymerization of three monomers is as follows:
式中:Tg=34~37℃,使形状记忆转变温度使其接近人体温度;Tg1、Tg2、和Tg3是D,L-丙交酯(55-60℃)、L-丙交酯(60-65℃)和三亚甲基环碳酸酯(-15℃)三种链段的玻璃化温度;W1、W2和W3是D,L-丙交酯、L-丙交酯和三亚甲基环碳酸酯三种链段的质量分数。In the formula: T g = 34-37°C, making the shape memory transition temperature close to the body temperature; T g1 , T g2 , and T g3 are D, L-lactide (55-60°C), L-lactide The glass transition temperature of three segments of ester (60-65°C) and trimethylene cyclocarbonate (-15°C); W 1 , W 2 and W 3 are D, L-lactide, L-lactide and the mass fractions of the three segments of trimethylene cyclocarbonate.
本发明的熔点在20℃-40℃的主体是以D,L-丙交酯或己内酯为主单体;L-丙交酯、己内酯、乙交酯、环酸酐、环碳酸酯、环磷脂或对二氧环己酮中的一种或多种作为共聚单体;经催化剂、引发剂作用后共聚得到多组分共聚物,并通过约束最终合成的主体的分子量为1000-4000左右,并控制引发剂用量为所有单体的总重的0.1wt%来实现。具体举例如下:The main body of the present invention whose melting point is between 20°C and 40°C is D, L-lactide or caprolactone as the main monomer; L-lactide, caprolactone, glycolide, cyclic anhydride, and cyclic carbonate One or more of cyclophospholipids or p-dioxanone are used as comonomers; multi-component copolymers are obtained by copolymerization after the action of catalysts and initiators, and the molecular weight of the final synthesized body is restricted to 1000-4000 About, and control the amount of initiator to be 0.1wt% of the total weight of all monomers to realize. Specific examples are as follows:
以辛酸亚锡为催化剂,二元或多元羟基化合物或低聚物为引发剂,以己内酯为主单体,D,L-丙交酯、L-丙交酯、己内酯、乙交酯、环酸酐、环碳酸酯、环磷脂、对二氧环己酮等中的一种、两种或三种以上为共聚单体。将上述所需反应物、引发剂和催化剂加入无水无氧反应瓶,抽真空,通氮气,反复三次。反应体系密封后在130℃的油浴下反应24h。反应完毕后,反应体系降至室温,加入适量的三氯甲烷溶解产物。将反应混合物缓慢滴加到冷甲醇中沉淀,其中甲醇的体积是5-10倍反应物的三氯甲烷溶液体积,过滤后再次溶解和沉淀,连续沉淀三次,得到的最终产物。其中,引发剂用量为(所有的)单体的0.1wt%;引发剂和单体的摩尔比根据所需分子量计算,最终合成的大分子分子量在1000~4000左右,熔点在30~40℃。Use stannous octoate as catalyst, binary or polyhydric hydroxyl compound or oligomer as initiator, caprolactone as main monomer, D, L-lactide, L-lactide, caprolactone, glycolide One, two or more of esters, cyclic anhydrides, cyclocarbonates, cyclophospholipids, p-dioxanone, etc. are comonomers. Add the above-mentioned required reactants, initiators and catalysts into an anhydrous and oxygen-free reaction flask, vacuumize, and pass nitrogen, and repeat three times. After the reaction system was sealed, it was reacted in an oil bath at 130°C for 24 hours. After the reaction was completed, the reaction system was cooled to room temperature, and an appropriate amount of chloroform was added to dissolve the product. The reaction mixture is slowly dropped into cold methanol for precipitation, wherein the volume of methanol is 5-10 times the volume of the chloroform solution of the reactant. After filtering, it dissolves and precipitates again, and precipitates continuously for three times to obtain the final product. Wherein, the amount of the initiator is 0.1wt% of (all) monomers; the molar ratio of the initiator and the monomer is calculated according to the required molecular weight, and the molecular weight of the final synthesized macromolecule is about 1000-4000, and the melting point is 30-40°C.
本发明在末端为羟基的生物可降解高分子进行了可降解改进的基础上,进一步进行降冰片烯基封端处理和巯基封端处理,从而得到可降解的4D打印材料。具体举例如下:In the present invention, on the basis of the degradable improvement of the biodegradable polymer with a hydroxyl terminal, further norbornene group capping treatment and mercapto group capping treatment are carried out, so as to obtain a degradable 4D printing material. Specific examples are as follows:
降冰片烯基封端生物可降解高分子的合成在反应瓶内加入羟基封端的可降解大分子、降冰片烯酰氯和三乙胺。其中,降冰片烯酰氯、三乙胺和羟基的摩尔比为1.2:1.2:1,溶剂为干燥的二氯甲烷,室温反应48h,反应完成后过滤,滤液在冷的甲醇中沉淀三次,室温真空干燥后低温保存备用。Synthesis of norbornene-terminated biodegradable macromolecules Add hydroxyl-terminated biodegradable macromolecules, norbornene acyl chloride and triethylamine into a reaction flask. Wherein, the molar ratio of norbornene acid chloride, triethylamine and hydroxyl is 1.2:1.2:1, the solvent is dry dichloromethane, react at room temperature for 48h, filter after the reaction is completed, and the filtrate is precipitated three times in cold methanol, and vacuum Store at low temperature after drying.
巯基封端生物可降解高分子的合成取羟基封端的可降解大分子置于连接分水器的两口烧瓶中,加入羟基摩尔量10倍的巯基乙酸和单体质量1wt%的一水对甲苯磺酸催化剂,然后加入溶剂,通氮气。反应物在120~126℃条件下回流反应24h。反应结束后,冷却,溶液在甲醇中沉淀三次,室温真空干燥后冷藏保存。Synthesis of mercapto-terminated biodegradable macromolecules: Take the hydroxyl-terminated degradable macromolecule and place it in a two-necked flask connected to the water separator, add thioglycolic acid with 10 times the molar amount of hydroxyl group and 1 wt% p-toluenesulfonate monohydrate Acid catalyst, then add solvent, pass nitrogen. The reactants were refluxed for 24 hours at 120-126°C. After the reaction was finished, it was cooled, and the solution was precipitated three times in methanol, dried in vacuum at room temperature, and stored in cold storage.
可降解的4D打印材料完成后,通过4D打印制备生物支架。该打印的基本方法是将所述生物可降解体温感应材料、溶剂、光引发剂与多官能团巯基小分子或降冰片烯小分子混匀调节至适合打印粘度后,所述多官能团巯基小分子或降冰片烯小分子与生物可降解体温感应材料通过4D打印,在紫外光的催化下发生降冰片烯-巯基光聚合反应;将生物支架加热到熔点温度或玻璃化温度以上并沿着直径方向压缩降低尺寸,然后在零度附近固定临时形状,即得到可降解体温感应记忆生物支架。After the degradable 4D printing material is completed, the bioscaffold is prepared by 4D printing. The basic method of printing is to mix the biodegradable body temperature sensing material, solvent, photoinitiator and multifunctional mercapto small molecules or norbornene small molecules to adjust to a suitable printing viscosity, and then the multifunctional mercapto small molecules or Norbornene small molecules and biodegradable body temperature sensing materials are 4D printed, and under the catalysis of ultraviolet light, a norbornene-mercapto photopolymerization reaction occurs; the bioscaffold is heated above the melting point temperature or glass transition temperature and compressed along the diameter direction The size is reduced, and then the temporary shape is fixed near zero to obtain a degradable bioscaffold with body temperature sensing memory.
该生物支架植入到人体后,在身体温度的激励下可以发生膨胀等自我变形,最终达到预设的三维空间构型,使其在植入人体时无需球囊扩张即可通过自我变形实现支架与血管内壁的紧密稳定贴合。After the biostent is implanted into the human body, it can undergo self-deformation such as expansion under the excitation of body temperature, and finally achieve a preset three-dimensional space configuration, so that it can realize the stent through self-deformation without balloon expansion when implanted in the human body. Tight and stable fit with the inner wall of the blood vessel.
该生物支架的聚合物网络是交联的三维网络,具有优异的形状记忆固定率、回复率、形状记忆循环性能、高可回复应变和可降解性能。The polymer network of the bioscaffold is a cross-linked three-dimensional network, which has excellent shape memory fixation rate, recovery rate, shape memory cycle performance, high recoverable strain and degradable performance.
本发明的4D打印可降解体温感应形状记忆血管支架的打印原理是基于光催化降冰片烯-巯基点击化学反应,具有打印速度快、无氧阻聚和无收缩的优点。基于此方法制备的形状记忆血管支架材料具有形状回复速度快,回复温度更加精确和可控的降解速率。The printing principle of the 4D printing degradable body temperature-sensitive shape memory vascular stent of the present invention is based on the photocatalytic norbornene-mercapto click chemical reaction, which has the advantages of fast printing speed, no oxygen inhibition and no shrinkage. The shape-memory vascular stent material prepared based on this method has a fast shape recovery speed, a more accurate recovery temperature and a controllable degradation rate.
优化后的打印条件如下:所述4D打印的打印条件为紫外光强度30mW/cm-2;打印速度:50mm/h,打印支架尺寸:长度40mm,外径4mm,内径2mm。The optimized printing conditions are as follows: the printing conditions of the 4D printing are ultraviolet light intensity 30mW/cm -2 ; printing speed: 50mm/h, printing support size: length 40mm, outer diameter 4mm, inner diameter 2mm.
对于上述合成的不同的生物可降解体温感应材料可以分别采用如下方式,进行4D打印制作生物支架。For the different biodegradable body temperature sensing materials synthesized above, the following methods can be used to perform 4D printing to make biological scaffolds.
生物可降解体温感应材料为末端为降冰片烯基的多组分生物可降解高分子时,所述生物支架的制备包括如下步骤:将所述生物可降解体温感应材料、溶剂、光引发剂与多官能团巯基小分子混匀调节至适合打印粘度(例如使打印时溶液的固含量保持在40%左右)后,通过4D打印得到生物支架;所述多官能团巯基小分子为四(3-巯基丙酸)季戊四醇酯。优选地,光引发剂为2,4,6(三甲基苯甲酰基)二苯基氧化膦;溶剂为三氯甲烷;光引发剂占各物质总重的质量分数为0.5wt%。When the biodegradable body temperature sensing material is a multi-component biodegradable polymer with a norbornene group at the end, the preparation of the bioscaffold includes the following steps: combining the biodegradable body temperature sensing material, a solvent, a photoinitiator and After the multifunctional mercapto small molecule is mixed and adjusted to a suitable printing viscosity (for example, the solid content of the solution during printing is kept at about 40%), the bioscaffold is obtained by 4D printing; the multifunctional mercapto small molecule is tetrakis(3-mercaptopropane acid) pentaerythritol ester. Preferably, the photoinitiator is 2,4,6(trimethylbenzoyl)diphenylphosphine oxide; the solvent is chloroform; and the mass fraction of the photoinitiator in the total weight of each substance is 0.5wt%.
生物可降解体温感应材料为末端为巯基的多组分生物可降解高分子时,生物支架的制备包括如下步骤:将所述生物可降解体温感应材料、溶剂、光引发剂与降冰片烯小分子混匀调节至适合打印粘度后,通过4D打印得到生物支架;所述降冰片烯小分子为5-降冰片烯-2-羧酸三羟甲基丙烷三酯。优选地,光引发剂为2,4,6(三甲基苯甲酰基)二苯基氧化膦;溶剂为三氯甲烷;光引发剂占各物质总重的质量分数为0.5wt%。When the biodegradable body temperature sensing material is a multi-component biodegradable polymer with a mercapto group at the end, the preparation of the bioscaffold includes the following steps: combining the biodegradable body temperature sensing material, a solvent, a photoinitiator and a norbornene small molecule After mixing and adjusting to a suitable printing viscosity, a bioscaffold is obtained by 4D printing; the norbornene small molecule is 5-norbornene-2-carboxylic acid trimethylolpropane triester. Preferably, the photoinitiator is 2,4,6(trimethylbenzoyl)diphenylphosphine oxide; the solvent is chloroform; and the mass fraction of the photoinitiator in the total weight of each substance is 0.5wt%.
实施例1Example 1
将0.076mmol辛酸亚锡、69.6mmol三亚甲基碳酸酯、309.6mmol D,L-丙交酯和50mmol季戊四醇加入无水无氧反应瓶,抽真空,通氮气,反复三次。反应体系密封后在130℃的油浴下反应24h。反应完毕后,反应体系降至室温,加入适量的三氯甲烷溶解产物。将反应混合物缓慢滴加到冷甲醇中沉淀,其中甲醇的体积是5-10倍反应物的三氯甲烷溶液体积,过滤后再次溶解和沉淀,得到羟基封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物(Mn=1568;Mw=1770;Tg=34~36℃),如图9所示的羟基封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物的Tanδ–温度曲线。Add 0.076mmol of stannous octoate, 69.6mmol of trimethylene carbonate, 309.6mmol of D, L-lactide and 50mmol of pentaerythritol into an anhydrous and oxygen-free reaction flask, vacuumize and blow nitrogen, repeat three times. After the reaction system was sealed, it was reacted in an oil bath at 130°C for 24 hours. After the reaction was completed, the reaction system was cooled to room temperature, and an appropriate amount of chloroform was added to dissolve the product. Slowly add the reaction mixture dropwise into cold methanol for precipitation, where the volume of methanol is 5-10 times the volume of the chloroform solution of the reactant, and then dissolve and precipitate again after filtration to obtain the hydroxyl-terminated four-arm poly D,L-lactate Ester-co-trimethylene carbonate copolymer ( Mn = 1568; Mw = 1770; Tg = 34 ~ 36 ° C), hydroxyl-terminated four-arm poly D, L-lactide as shown in Figure 9 Tan δ–temperature curves of -co-trimethylene carbonate copolymers.
将羟基封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物、降冰片烯酰氯和三乙胺放入三口瓶。其中,降冰片烯酰氯、三乙胺和羟基的摩尔比为1.2:1.2:1,溶剂为干燥的二氯甲烷,室温反应48h,反应完成后过滤,滤液在冷的甲醇中沉淀三次,室温真空干燥后得到降冰片烯封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物。Put hydroxyl-terminated four-arm poly D,L-lactide-co-trimethylene carbonate copolymer, norbornene acid chloride and triethylamine into a three-necked flask. Wherein, the molar ratio of norbornene acid chloride, triethylamine and hydroxyl is 1.2:1.2:1, the solvent is dry dichloromethane, react at room temperature for 48h, filter after the reaction is completed, and the filtrate is precipitated three times in cold methanol, and vacuum After drying, a norbornene-terminated four-arm poly D, L-lactide-co-trimethylene carbonate copolymer was obtained.
以三氯甲烷为溶剂,降冰片烯封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物、四(3-巯基丙酸)季戊四醇酯、2,4,6(三甲基苯甲酰基)二苯基氧化膦混合均匀,降冰片烯基和巯基摩尔比1:1,光引发剂质量分数0.5wt%。调节溶液的固含量为40%,通过降冰片烯-巯基光固化成型打印技术打印支架材料,紫外光强度为20mW/cm-2;打印支架尺寸:长度40mm,外径4mm,内径2mm;打印速度:80mm/h。经过光交联后材料玻璃化温度有3℃的增大。将打印好的支架加热到40℃,直径方向压缩降低尺寸,然后在零度附近固定临时形状,即可得到可降解体温感应形状记忆聚合物血管支架。With chloroform as solvent, norbornene-terminated four-arm poly D,L-lactide-co-trimethylene carbonate copolymer, tetrakis(3-mercaptopropionic acid)pentaerythritol ester, 2,4,6( Trimethylbenzoyl)diphenylphosphine oxide is mixed evenly, the molar ratio of norbornene group and mercapto group is 1:1, and the mass fraction of photoinitiator is 0.5wt%. The solid content of the solution is adjusted to 40%, and the scaffold material is printed by norbornene-mercapto photocuring printing technology, and the ultraviolet light intensity is 20mW/cm -2 ; the size of the printed scaffold: length 40mm, outer diameter 4mm, inner diameter 2mm; printing speed : 80mm/h. The glass transition temperature of the material increased by 3°C after photocrosslinking. The printed stent is heated to 40°C, compressed in the diameter direction to reduce the size, and then the temporary shape is fixed near zero degrees to obtain a degradable body temperature-sensitive shape memory polymer vascular stent.
实施例2Example 2
本实施例与实施例1相比,除具备以下不同之处之外,其余相同。不同的仅仅是:四(3-巯基丙酸)季戊四醇酯替换为三羟甲基丙烷三(3-巯基丙酸酯)。Compared with Embodiment 1, this embodiment is the same except for the following differences. The only difference is that tetrakis(3-mercaptopropionate) pentaerythritol is replaced by trimethylolpropane tris(3-mercaptopropionate).
实施例3Example 3
本实施例与实施例1相比,除具备以下不同之处之外,其余相同。不同的仅仅是:四(3-巯基丙酸)季戊四醇酯替换为异氰脲酸三[2-(3-巯基丙酰氧基)乙酯]。Compared with Embodiment 1, this embodiment is the same except for the following differences. The only difference is that tetrakis(3-mercaptopropionate) pentaerythritol is replaced by tris[2-(3-mercaptopropionyloxy)ethyl isocyanurate].
实施例4Example 4
本实施例与实施例1相比,除具备以下不同之处之外,其余相同。不同是:将季戊四醇替换为1,4-丁二醇,得到线型聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物。另外,所选择的多官能团巯基化合物的巯基数量至少为三个。Compared with Embodiment 1, this embodiment is the same except for the following differences. The difference is: replace pentaerythritol with 1,4-butanediol to obtain linear poly-D,L-lactide-co-trimethylene carbonate copolymer. In addition, the selected polyfunctional mercapto compound has at least three mercapto groups.
乙二醇、季戊四醇、小分子多羟基醇、低聚二臂聚乙二醇、多臂聚乙二醇、低聚二臂聚己内酯多元醇、多臂聚己内酯多元醇、低聚二臂聚醚多元醇、三臂聚醚多元醇、环糊精或糖醇Ethylene glycol, pentaerythritol, small molecule polyhydric alcohol, oligomeric two-arm polyethylene glycol, multi-arm polyethylene glycol, oligomeric two-arm polycaprolactone polyol, multi-arm polycaprolactone polyol, oligomeric Two-arm polyether polyol, three-arm polyether polyol, cyclodextrin or sugar alcohol
实施例5Example 5
本实施例与实施例1相比,除具备以下不同之处之外,其余相同。不同是:将69.6mmol三亚甲基碳酸酯替换为:90mmol三亚甲基碳酸酯和10mmol的L-丙交酯或乙交酯或环酸酐或环磷脂中的一种或多种。Compared with Embodiment 1, this embodiment is the same except for the following differences. The difference is: 69.6mmol of trimethylene carbonate is replaced by: 90mmol of trimethylene carbonate and 10mmol of one or more of L-lactide or glycolide or cyclic anhydride or cyclophospholipid.
实施例6Example 6
本实施例与实施例1相比,除具备以下不同之处之外,其余相同。不同是:将季戊四醇替换为低聚二臂聚乙二醇、低聚二臂聚己内酯多元醇或低聚二臂聚醚多元醇,得到线型聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物。另外,所选择的多官能团巯基化合物的巯基数量至少为三个。Compared with Embodiment 1, this embodiment is the same except for the following differences. The difference is: replace pentaerythritol with oligomeric two-arm polyethylene glycol, oligomeric two-arm polycaprolactone polyol or oligomeric two-arm polyether polyol to obtain linear poly D,L-lactide-co- Trimethylene carbonate copolymer. In addition, the selected polyfunctional mercapto compound has at least three mercapto groups.
实施例7Example 7
本实施例与实施例1相比,除具备以下不同之处之外,其余相同。不同是:将季戊四醇替换为多臂聚乙二醇、多臂聚己内酯多元醇或三臂聚醚多元醇低聚物,得到线型聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物。另外,所选择的多官能团巯基化合物的巯基数量至少为两个。Compared with Embodiment 1, this embodiment is the same except for the following differences. The difference is: replace pentaerythritol with multi-arm polyethylene glycol, multi-arm polycaprolactone polyol or three-arm polyether polyol oligomer to obtain linear poly-D,L-lactide-co-trimethylene carbonate copolymer. In addition, the selected polyfunctional mercapto compound has at least two mercapto groups.
实施例8Example 8
本实施例与实施例1相比,除具备以下不同之处之外,其余相同。不同是:将季戊四醇替换为双季戊四醇,得到六臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物。多官能团巯基小分子可以是:乙二硫醇、1,4-丁二硫醇、1,6-己二硫醇、四(3-巯基丙酸)季戊四醇酯、异氰脲酸三[2-(3-巯基丙酰氧基)乙酯]、三羟甲基丙烷三(3-巯基丙酸酯)等。Compared with Embodiment 1, this embodiment is the same except for the following differences. The difference is: replace pentaerythritol with dipentaerythritol to obtain six-arm poly D, L-lactide-co-trimethylene carbonate copolymer. Small molecules with multifunctional mercapto groups can be: ethanedithiol, 1,4-butanedithiol, 1,6-hexanedithiol, tetrakis(3-mercaptopropionic acid) pentaerythritol ester, tri[2-isocyanurate (3-mercaptopropionyloxy)ethyl ester], trimethylolpropane tris(3-mercaptopropionate), etc.
实施例9Example 9
本实施例中羟基封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物的合成与实施例1相同。The synthesis of the hydroxyl-terminated four-arm poly D,L-lactide-co-trimethylene carbonate copolymer in this example is the same as that in Example 1.
将羟基封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物置于连接分水器的两口烧瓶中,加入羟基摩尔量10倍的巯基乙酸和单体质量1wt%的一水对甲苯磺酸催化剂,然后加入溶剂,通氮气。反应物在120~126℃条件下回流反应24h。反应结束后,冷却,溶液在甲醇中沉淀三次,室温真空干燥后冷藏保存。Put the hydroxyl-terminated four-arm poly D, L-lactide-co-trimethylene carbonate copolymer in a two-necked flask connected to the water separator, add thioglycolic acid with 10 times the molar amount of hydroxyl groups and 1 wt% of the monomer mass One water p-toluenesulfonic acid catalyst, then add solvent, nitrogen. The reactants were refluxed for 24 hours at 120-126°C. After the reaction was finished, it was cooled, and the solution was precipitated three times in methanol, dried in vacuum at room temperature, and stored in cold storage.
以三氯甲烷为溶剂,巯基封端的四臂聚D,L-丙交酯-co-三亚甲基碳酸酯共聚物、5-降冰片烯-2-羧酸三羟甲基丙烷三酯、2,4,6(三甲基苯甲酰基)二苯基氧化膦)混合均匀,降冰片烯基和巯基摩尔比1:1,光引发剂质量分数0.5wt%。调节溶液的固含量为40%,通过降冰片烯-巯基光固化成型打印技术打印支架材料,紫外光强度为30mW/cm-2;打印支架尺寸:长度40mm,外径4mm,内径2mm;打印速度:50mm/h。经过光交联后材料玻璃化温度有3℃的增大。将打印好的支架加热到40℃,直径方向压缩降低尺寸,然后在零度附近固定临时形状,即可得到可降解体温感应形状记忆聚合物血管支架。With chloroform as solvent, mercapto-terminated four-arm poly D, L-lactide-co-trimethylene carbonate copolymer, 5-norbornene-2-carboxylic acid trimethylolpropane triester, 2 , 4,6 (trimethylbenzoyl) diphenylphosphine oxide) were mixed uniformly, the molar ratio of norbornene group and mercapto group was 1:1, and the mass fraction of photoinitiator was 0.5wt%. The solid content of the solution is adjusted to 40%, and the scaffold material is printed by norbornene-mercapto photocuring printing technology, and the ultraviolet light intensity is 30mW/cm -2 ; the size of the printed scaffold: length 40mm, outer diameter 4mm, inner diameter 2mm; printing speed : 50mm/h. The glass transition temperature of the material increased by 3°C after photocrosslinking. The printed stent is heated to 40°C, compressed in the diameter direction to reduce the size, and then the temporary shape is fixed near zero degrees to obtain a degradable body temperature-sensitive shape memory polymer vascular stent.
实施例10Example 10
本实施例与实施例9相比,除具备以下不同之处之外,其余相同。不同的仅仅是:5-降冰片烯-2-羧酸三羟甲基丙烷三酯替换为5-降冰片烯-2-羧酸四羟甲基丙烷四酯。Compared with Embodiment 9, this embodiment is the same except for the following differences. The only difference is that trimethylolpropane 5-norbornene-2-carboxylate triester is replaced by tetramethylolpropane 5-norbornene-2-carboxylate tetraester.
实施例11Example 11
本实施例与实施例9相比,除具备以下不同之处之外,其余相同。不同的仅仅是:5-降冰片烯-2-羧酸三羟甲基丙烷三酯替换为1,6-己二醇5-降冰片烯-2-羧酸酯。Compared with Embodiment 9, this embodiment is the same except for the following differences. The only difference is: Trimethylolpropane 5-norbornene-2-carboxylate triester is replaced by 1,6-hexanediol 5-norbornene-2-carboxylate.
实施例12Example 12
在无水无氧反应瓶内加入ε-己内酯、三亚甲基碳酸酯、1,6-丁二醇和辛酸亚锡为催化剂,减压抽真空三次,反应体系密封后在130℃的油浴下反应24h。反应完毕后,反应体系降至室温,加入适量的三氯甲烷溶解产物。将反应混合物缓慢滴加到冷甲醇中沉淀,其中甲醇的体积是5-10倍反应物的三氯甲烷溶液体积,过滤后再次溶解和沉淀,连续沉淀三次,得到的最终产物线型羟基封端的聚(己内酯-co-三亚甲基碳酸酯)。其中,引发剂用量为单体的0.1wt%;ε-己内酯和三亚甲基碳酸酯的摩尔比为80:20;引发剂和单体的摩尔比1:25,最终合成的羟基封端的聚(己内酯-co-三亚甲基碳酸酯)熔点在34~38℃,附图10。Add ε-caprolactone, trimethylene carbonate, 1,6-butanediol and stannous octoate as catalysts in an anhydrous and oxygen-free reaction flask, depressurize and evacuate three times, and seal the reaction system in an oil bath at 130°C Under reaction 24h. After the reaction was completed, the reaction system was cooled to room temperature, and an appropriate amount of chloroform was added to dissolve the product. The reaction mixture is slowly dropped into cold methanol for precipitation, wherein the volume of methanol is 5-10 times the volume of the chloroform solution of the reactant. After filtration, it dissolves and precipitates again, and precipitates continuously for three times. The final product obtained is linear hydroxyl-terminated Poly(caprolactone-co-trimethylene carbonate). Wherein, the amount of the initiator is 0.1wt% of the monomer; the molar ratio of ε-caprolactone and trimethylene carbonate is 80:20; the molar ratio of the initiator and the monomer is 1:25, and the final synthesized hydroxyl-terminated Poly(caprolactone-co-trimethylene carbonate) has a melting point of 34-38°C, as shown in Figure 10.
将羟基封端的线型羟基封端的聚(己内酯-co-三亚甲基碳酸酯)共聚物置于连接分水器的两口烧瓶中,加入羟基摩尔量10倍的巯基乙酸和单体质量1wt%的一水对甲苯磺酸催化剂,然后加入溶剂,通氮气。反应物在120~126℃条件下回流反应24h。反应结束后,冷却,溶液在甲醇中沉淀三次,室温真空干燥后冷藏保存。The linear hydroxyl-terminated poly(caprolactone-co-trimethylene carbonate) copolymer of hydroxy-termination is placed in the two-necked flask connected to the water separator, and thioglycolic acid and monomer mass 1wt% of hydroxyl molar weight 10 times are added A water-based p-toluenesulfonic acid catalyst, and then add solvent, nitrogen. The reactants were refluxed for 24 hours at 120-126°C. After the reaction was finished, it was cooled, and the solution was precipitated three times in methanol, dried in vacuum at room temperature, and stored in cold storage.
以三氯甲烷为溶剂,线型巯基封端的聚(己内酯-co-三亚甲基碳酸酯)、5-降冰片烯-2-羧酸三羟甲基丙烷三酯、2,4,6(三甲基苯甲酰基)二苯基氧化膦混合均匀,降冰片烯基和巯基摩尔比1:1,光引发剂质量分数0.5wt%。调节溶液的固含量为40%,通过降冰片烯-巯基光固化成型打印技术打印支架材料,紫外光强度为30mW/cm-2;打印支架尺寸:长度40mm,外径4mm,内径2mm;打印速度:50mm/h。经过光交联后材料玻璃化温度有3℃的增大。将打印好的支架加热到40℃,直径方向压缩降低尺寸,然后在零度附近固定临时形状,即可得到可降解体温感应形状记忆聚合物血管支架。In chloroform as solvent, linear thiol-terminated poly(caprolactone-co-trimethylene carbonate), 5-norbornene-2-carboxylic acid trimethylolpropane triester, 2,4,6 (Trimethylbenzoyl)diphenylphosphine oxide is mixed evenly, the molar ratio of norbornene group and mercapto group is 1:1, and the mass fraction of photoinitiator is 0.5wt%. The solid content of the solution is adjusted to 40%, and the scaffold material is printed by norbornene-mercapto photocuring printing technology, and the ultraviolet light intensity is 30mW/cm -2 ; the size of the printed scaffold: length 40mm, outer diameter 4mm, inner diameter 2mm; printing speed : 50mm/h. The glass transition temperature of the material increases by 3°C after photocrosslinking. The printed stent is heated to 40°C, compressed in the diameter direction to reduce the size, and then the temporary shape is fixed near zero degrees to obtain a degradable body temperature-sensitive shape memory polymer vascular stent.
实施例13Example 13
本实施例与实施例12相比,除具备以下不同之处之外,其余相同。不同的仅仅是:5-降冰片烯-2-羧酸三羟甲基丙烷三酯替换为5-降冰片烯-2-羧酸四羟甲基丙烷四酯。Compared with Embodiment 12, this embodiment is the same except for the following differences. The only difference is that trimethylolpropane 5-norbornene-2-carboxylate triester is replaced by tetramethylolpropane 5-norbornene-2-carboxylate tetraester.
实施例14Example 14
本实施例与实施例12相比,除具备以下不同之处之外,其余相同。不同的仅仅是:5-降冰片烯-2-羧酸三羟甲基丙烷三酯替换为降冰片烯封端的超支化聚合物。Compared with Embodiment 12, this embodiment is the same except for the following differences. The only difference is that trimethylolpropane 5-norbornene-2-carboxylate triester is replaced by a norbornene-terminated hyperbranched polymer.
实施例15Example 15
本实施例与实施例12相比,除具备以下不同之处之外,其余相同。不同的仅仅是:5-降冰片烯-2-羧酸三羟甲基丙烷三酯替换为1,6-己二醇5-降冰片烯-2-羧酸酯。Compared with Embodiment 12, this embodiment is the same except for the following differences. The only difference is: Trimethylolpropane 5-norbornene-2-carboxylate triester is replaced by 1,6-hexanediol 5-norbornene-2-carboxylate.
实施例16Example 16
本实施例与实施例12相比,除具备以下不同之处之外,其余相同。不同的是:1,6-己二醇替换为聚乙二醇,分子量为500~1000;三亚甲基碳酸酯单体除去;制备聚乙二醇引发聚合的线性聚己内酯,同样得到熔点在38~40℃的可降解聚合物。Compared with Embodiment 12, this embodiment is the same except for the following differences. The difference is: 1,6-hexanediol is replaced by polyethylene glycol, with a molecular weight of 500-1000; the trimethylene carbonate monomer is removed; the linear polycaprolactone that is polymerized by polyethylene glycol is prepared, and the melting point is also obtained Degradable polymer at 38-40°C.
实施例17Example 17
本实施例与实施例12相比,除具备以下不同之处之外,其余相同。不同的是:1,6-己二醇替换为季戊四醇或环糊精或糖醇。Compared with Embodiment 12, this embodiment is the same except for the following differences. The difference is: 1,6-hexanediol is replaced by pentaerythritol or cyclodextrin or sugar alcohol.
实施例18Example 18
本实施例与实施例12相比,除具备以下不同之处之外,其余相同。不同的是:1,6-己二醇替换为羟基封端的超支化聚合物。Compared with Embodiment 12, this embodiment is the same except for the following differences. The difference is: 1,6-hexanediol is replaced by a hydroxyl-terminated hyperbranched polymer.
实施例19Example 19
本实施例与实施例12相比,除具备以下不同之处之外,其余相同。不同是:将三亚甲基碳酸酯替换为:三亚甲基碳酸酯和L-丙交酯或乙交酯或环酸酐或环磷脂的一种或多种。Compared with Embodiment 12, this embodiment is the same except for the following differences. The difference is: the trimethylene carbonate is replaced by: one or more of trimethylene carbonate and L-lactide or glycolide or cyclic anhydride or cyclophospholipid.
实施例20Example 20
本实施例与实施例12相比,除具备以下不同之处之外,其余相同。不同是:将三亚甲基碳酸酯替换为:D,L-丙交酯和L-丙交酯或乙交酯或环酸酐或环磷脂的一种或多种。Compared with Embodiment 12, this embodiment is the same except for the following differences. The difference is: the trimethylene carbonate is replaced by: one or more of D, L-lactide and L-lactide or glycolide or cyclic anhydride or cyclophospholipid.
实施例21Example 21
线型羟基封端的聚(己内酯-co-三亚甲基碳酸酯)共聚物的合成与实施例9相同。The synthesis of linear hydroxyl-terminated poly(caprolactone-co-trimethylene carbonate) copolymer was the same as in Example 9.
将羟基封端的线型羟基封端的聚(己内酯-co-三亚甲基碳酸酯)共聚物、降冰片烯酰氯和三乙胺放入三口瓶。其中,降冰片烯酰氯、三乙胺和羟基的摩尔比为1.2:1.2:1,溶剂为干燥的二氯甲烷,室温反应48h,反应完成后过滤,滤液在冷的甲醇中沉淀三次,室温真空干燥后得到降冰片烯封端的线型聚(己内酯-co-三亚甲基碳酸酯)共聚物。Put hydroxyl-terminated linear hydroxyl-terminated poly(caprolactone-co-trimethylene carbonate) copolymer, norbornene acid chloride and triethylamine into a three-neck flask. Wherein, the molar ratio of norbornene acid chloride, triethylamine and hydroxyl is 1.2:1.2:1, the solvent is dry dichloromethane, react at room temperature for 48h, filter after the reaction is completed, and the filtrate is precipitated three times in cold methanol, and vacuum A norbornene-terminated linear poly(caprolactone-co-trimethylene carbonate) copolymer was obtained after drying.
共聚物的打印过程与实施例12基本相同。不同的是线型巯基封端的聚(己内酯-co-三亚甲基碳酸酯)和5-降冰片烯-2-羧酸三羟甲基丙烷三酯分别替换为降冰片烯封端的线型聚(己内酯-co-三亚甲基碳酸酯)共聚物和四(3-巯基丙酸)季戊四醇酯。The printing process of the copolymer is basically the same as in Example 12. The difference is that the linear thiol-terminated poly(caprolactone-co-trimethylene carbonate) and 5-norbornene-2-carboxylic acid trimethylolpropane triester were replaced by norbornene-terminated linear Poly(caprolactone-co-trimethylene carbonate) copolymer and pentaerythritol tetrakis(3-mercaptopropionate).
实施例22Example 22
本实施例与实施例21相比,除具备以下不同之处之外,其余相同。不同的仅仅是:四(3-巯基丙酸)季戊四醇酯替换为巯基封端的超支化聚合物。Compared with Embodiment 21, this embodiment is the same except for the following differences. The only difference is that pentaerythritol tetrakis(3-mercaptopropionate) is replaced by a mercapto-terminated hyperbranched polymer.
实施例23Example 23
本实施例与实施例21相比,除具备以下不同之处之外,其余相同。不同的是:1,6-己二醇替换为低聚二臂聚乙二醇、多臂聚乙二醇、低聚二臂聚醚多元醇或三臂聚醚多元醇中的一种或多种,分子量为500~1000;三亚甲基碳酸酯单体除去;制备聚乙二醇引发聚合的线性聚己内酯,同样得到熔点在38~40℃的可降解聚合物。Compared with Embodiment 21, this embodiment is the same except for the following differences. The difference is: 1,6-hexanediol is replaced by one or more of oligomeric two-arm polyethylene glycol, multi-arm polyethylene glycol, oligomeric two-arm polyether polyol or three-arm polyether polyol species, the molecular weight is 500-1000; the trimethylene carbonate monomer is removed; the linear polycaprolactone that is polymerized by polyethylene glycol is prepared, and a degradable polymer with a melting point of 38-40 DEG C is also obtained.
实施例24Example 24
本实施例与实施例21相比,除具备以下不同之处之外,其余相同。不同的是:1,6-己二醇替换为季戊四醇。Compared with Embodiment 21, this embodiment is the same except for the following differences. The difference is: 1,6-hexanediol is replaced by pentaerythritol.
实施例25Example 25
本实施例与实施例21相比,除具备以下不同之处之外,其余相同。不同的是:1,6-己二醇替换为羟基封端的超支化聚合物。Compared with Embodiment 21, this embodiment is the same except for the following differences. The difference is: 1,6-hexanediol is replaced by a hydroxyl-terminated hyperbranched polymer.
本发明不局限于上述可选的实施方式,任何人在本发明的启示下都可得出其他各种形式的产品。上述具体实施方式不应理解成对本发明的保护范围的限制,以上所述仅为本发明的优选实例,并不用于限制本发明。在不违背本发明原理的情形下,本发明可以进行各种更改和变化,凡对本发明所作的任何修改,等同替换,改性等,均应包含在本发明的保护范围内。The present invention is not limited to the above optional embodiments, and anyone can obtain other various forms of products under the enlightenment of the present invention. The above specific implementation manners should not be understood as limiting the protection scope of the present invention, and the above descriptions are only preferred examples of the present invention, and are not intended to limit the present invention. Without violating the principle of the present invention, the present invention can carry out various changes and changes, and any modification, equivalent replacement, modification, etc. made to the present invention should be included in the protection scope of the present invention.
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910860265.1A CN110527075A (en) | 2019-09-11 | 2019-09-11 | A kind of preparation method for remembering biological support for the biodegradable body temperature inductive material of 4D printing and the induction of degradable body temperature |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910860265.1A CN110527075A (en) | 2019-09-11 | 2019-09-11 | A kind of preparation method for remembering biological support for the biodegradable body temperature inductive material of 4D printing and the induction of degradable body temperature |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110527075A true CN110527075A (en) | 2019-12-03 |
Family
ID=68668433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910860265.1A Pending CN110527075A (en) | 2019-09-11 | 2019-09-11 | A kind of preparation method for remembering biological support for the biodegradable body temperature inductive material of 4D printing and the induction of degradable body temperature |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110527075A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111497220A (en) * | 2020-03-24 | 2020-08-07 | 深圳大学 | Shape memory sensor and method for manufacturing the same |
CN112126075A (en) * | 2020-09-23 | 2020-12-25 | 兰州大学第二医院 | Degradable shape memory polymer and preparation method thereof, 4D printing degradable lower extremity vascular stent and preparation method thereof |
-
2019
- 2019-09-11 CN CN201910860265.1A patent/CN110527075A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111497220A (en) * | 2020-03-24 | 2020-08-07 | 深圳大学 | Shape memory sensor and method for manufacturing the same |
CN112126075A (en) * | 2020-09-23 | 2020-12-25 | 兰州大学第二医院 | Degradable shape memory polymer and preparation method thereof, 4D printing degradable lower extremity vascular stent and preparation method thereof |
CN112126075B (en) * | 2020-09-23 | 2022-06-07 | 兰州大学第二医院 | Degradable shape memory polymer and preparation method thereof, and 4D printing degradable lower limb vascular stent and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101443055B (en) | Removal of tubular tissue supports | |
KR101906472B1 (en) | A photo-crosslinkable shape memory polymer and manufacturing method thereof | |
EP1729783B1 (en) | Biodegradable polyurethane and polyurethane ureas | |
CA3005306C (en) | Biodegradable block polyurethane copolymers comprising folic acid and their use in medical devices | |
WO2004036995A1 (en) | Copolymer of unsaturated epoxide, cyclic ester and hydrophilic segment | |
EP1874525B1 (en) | Hydrophilic/hydrophobic polymer networks based on poly(caprolactone fumarate), poly(ethylene glycol fumarate), and copolymers thereof | |
CN103709691A (en) | Biodegradable cross-linked polymer, and preparation method thereof | |
CN105209078B (en) | Polymer compositions with enhanced radiopacity | |
EP2075273A1 (en) | Multiple shape memory polymer networks | |
JP2022508631A (en) | Nasolacrimal duct insertion member containing shape memory polymer | |
KR102208921B1 (en) | Shape memory polymer, preparation method thereof, and the use of the same | |
CN110527075A (en) | A kind of preparation method for remembering biological support for the biodegradable body temperature inductive material of 4D printing and the induction of degradable body temperature | |
CN108264623A (en) | A kind of polyester polyurethane shape-memory material and preparation method thereof | |
CN111590914A (en) | 4D deformable mesh hollow degradable vascular stent with concave-convex structure on both inner and outer surfaces, and preparation and use methods thereof | |
Chen et al. | Biodegradable poly (trimethylene carbonate‐b‐(L‐lactide‐ran‐glycolide)) terpolymers with tailored molecular structure and advanced performance | |
Lei et al. | Synthesis, characterization and cytocompatibility of a degradable polymer using ferric catalyst for esophageal tissue engineering | |
WO2005002596A1 (en) | Biocompatible polymer networks | |
EP2075272A1 (en) | Shape memory polymer networks from crosslinkable thermoplasts | |
KR20220118841A (en) | Shape memory polymer and manufacturing method thereof, and the use of the same | |
JP7656536B2 (en) | Crosslinked radiopaque bioabsorbable polymers and devices made therefrom - Patents.com | |
US20230148372A1 (en) | Degradable, Printable Poly(Propylene Fumarate)-Based ABA Triblock Elastomers | |
KR20220118848A (en) | Shape memory polymer and manufacturing method thereof, and the use of the same | |
KR20220118843A (en) | Shape memory polymer and manufacturing method thereof, and the use of the same | |
CN113416302A (en) | Mercaptan-acrylate biomaterial and preparation method and application thereof | |
WO2025036795A1 (en) | Shape-memory polymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191203 |